Table 1.
Comparison of targeted arginine metabolism tracers.
| Tracer | Organic Synthesis | Radiolabeling | Evaluation | 
|---|---|---|---|
| (2S,4S)4-[18F]F PArg [32,33] | 10 step, Configuration determination | 2 step, yield < 6% | Targeting CAT transporters; PET imaging, MCF-7 (T/M = 6) and U87MG (T/M = 6) subcutaneous tumor, U87MG (T/B =1.5) and HS683 (T/B = 6.5) intracranial tumor, at 60 min p.i. | 
| [18F]7 | 10 step, Configuration determination | 2 step, yield = 8% | Targeting CAT, ASC, ASC2 transporters, PET imaging, MCF-7 Tumor (T/M = 4), intracranial tumor (T/B = 2) at 60 min p.i. | 
| L2 [30] | 3 step, Configuration determination | 1 step, yield = 100% | Targeting y+ transporters, no PET Imaging | 
| [18F]FPARG [31] | 4 step, Configuration undetermined | 5 step, yield = 15 ± 3% | No testing of transport mechanism, PET imaging, NCI-H460 Tumor (T/M = 2) at 60 min p.i. | 
CAT: Cationic amino acid transporter, p.i.: post injection, T/M: Tumor/Muscle, T/B: Tumor/Brain.